THANK YOU FOR SUBSCRIBING
Pharma Tech Outlook Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Pharma Tech Outlook
“Today, there is a convergence of promotional and medical requirements regarding the creation, approval, and use of digital content and pharmaceutical companies are struggling to find resources with the experience to assist in these regards,” begins Chris Taylor, President and Co-Founder, Framework Solutions, Inc. (Frameworks). “Simultaneously, there is an ever-expanding need to manage post-approval digital content, inside this very punitive regulated ecosystem.”
Frameworks’ goal is to transform their clients’ Promotional & Medical Review Process through insights, analytics, and logistical support. Offering a comprehensive suite of professional, process management/ coordination services supported by in-depth expertise and analytics, Frameworks is uniquely positioned to drive tremendous value and quality in the pharmaceutical space. Whether the need revolves around designing a content review model from scratch or enhancing a client’s existing processes, Frameworks specializes in developing and implementing end-to-end, insights-based solutions. They provide dynamic reporting, complete process optimization, and ongoing coordination while tailoring its offerings to suit client requirements. They facilitate the entire process from pre-review of content and schedule management to approval and release while keeping in mind FDA and regulatory restrictions.
“Companies spend vast amounts of money on infrastructure (systems and people) to help build compliant solutions, and we make sure that our clients realize a return on those investments while also driving value to upstream and downstream stakeholders,” remarks Taylor. Frameworks’ process managers/coordinators have facilitated the review and approval of over 300K marketing assets since the inception of the service and it comes as no surprise that clients invariably observe a significant increase in productivity and decrease in overall operational costs.
Companies spend vast amounts of money on infrastructure to help build compliant solutions, and we make sure that our clients realize a return on those investments
To drive maximum value from commercial and medical review data, Frameworks also offers state-of-the-art analytics and scorecarding to drive efficiency and increase ROI. Additionally, in response to the growing trend towards digital marketing, Frameworks digital asset management initiatives emerge as the proven solution of choice for effective and compliant use of digital content across multiple platforms and content management systems.
Always staying ahead of industry trends and placing customer needs above all, the company recently opened a processing facility in Cincinnati, OH that will be capable of facilitating the additional review of 75,0000 to 100,000 pieces of medical material per year. Further, investments have also been made in internal training and technology. “At present, we are focusing on both existing and pre-commercial pharma companies. The latter can leverage the Frameworks infrastructure prior to their New Drug Application (NDA) and PDUFA (expected approval) dates, thus allowing them to focus their budget on their commercial and medical activities and speeding their time to market,” ends Taylor.
Company
Framework Solutions
Management
Chris Taylor, President & Co-Founder
Description
Framework Solutions offers superior services and solutions to the pharmaceutical and life science industry. The company is the leader in the area of promotional and medical review. Framework Solutions Strategic Services group, with its in-depth industry knowledge, will transform your business process through targeted strategy, insight & analytics. The company’s on-demand solution allows you to scale your business more efficiently and cost-effectively. Utilizing their Promotional & Medical Review (PMR) Dashboard will enable them to quickly view the overall status of their digital assets and where they are in the process
"We are extremely pleased to welcome Russ to the Executive team," said Joe Walsh, CEO of Frameworks. "Russ is an accomplished biotech leader with a proven track record of commercialization success. Russ will play an integral role in helping the company expand its commercial offerings. We look forward to Russ contributing to the continued growth of the company." added Walsh.
Prior to Frameworks, Russ spent 16 years in the early days of Genentech Commercial and the past 20 years leading commercialization and commercial assessments at over 100 emerging biotech companies. He is the Commercial Expert in the California Life Sciences Institute's (CLSI) FAST program and the co-creator & co-leader of a 3-day revenue forecasting course for the Biotech Primer. Russ has a results-driven mindset, and his expertise is in all forms of commercialization, commercial and competitive assessments, and gaining alignment of Executive teams & boards on commercialization.
"I have been very impressed with Frameworks' expertise and capabilities," said Russ Belden. "I look forward to adding an array of go-to-market commercial services for emerging biopharma and several unique, highly differentiated services for established mid to large commercial organizations."